| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $75.5M | +3.3% |
| SG&A Expense | $18.5M | -1.4% |
| Operating Income | -$29.7M | +29.7% |
| Interest Expense | $2K | -83.3% |
| Pre-tax Income | -$29.5M | +30.5% |
| Income Tax | $272K | — |
| Net Income | -$29.8M | +29.8% |
| EPS (Basic) | -$0.43 | +46.9% |
| EPS (Diluted) | -$0.43 | +46.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.7M | -45.2% |
| Accounts Receivable | $5.8M | +8.9% |
| Current Assets | $45.1M | -37.1% |
| Total Assets | $47.6M | -36.8% |
| Current Liabilities | $30.0M | -11.9% |
| Total Liabilities | $50.5M | -6.1% |
| Stockholders' Equity | -$2.9M | -113.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.5M | -12.8% |
| Capital Expenditures | $118K | +187.8% |
| Investing Cash Flow | -$118K | -187.8% |
| Financing Cash Flow | -$951K | -102.1% |
| Free Cash Flow | -$28.6M | -13.1% |